Omnia SanaPlant Comparison
Greater Burdock vs Goldenseal
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Burdock and Goldenseal: they share 5 indicated uses (arthritis / joint pain, bloating, indigestion, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Greater Burdock | Goldenseal | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 5/10 | Stronger for Goldenseal |
| Bloating | 2/10 | 5/10 | Stronger for Goldenseal |
| Indigestion | 2/10 | 5/10 | Stronger for Goldenseal |
| Inflammation (general) | 2/10 | 5/10 | Stronger for Goldenseal |
| Skin irritation | 2/10 | 5/10 | Stronger for Goldenseal |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Burdock root is a rich source of prebiotic inulin-type fructans (fructooligosaccharides) along with chlorogenic and caffeic acids, the lignans arctiin and arctigenin, cynarine and quercetin, which underlie its antioxidant, anti-inflammatory and gut-supporting activity.
Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.
Pharmacological Actions
Burdock (Arctium lappa) extracts and the lignan arctigenin inhibit proliferation and induce apoptosis in colon, breast, lung and gastric cancer cells, attenuate melanoma progression and reduce preneoplastic colon lesions in vivo (preclinical).
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from digestive action
Arctium lappa root reduces diet-induced preneoplastic colon lesions and suppresses melanoma progression; its lignan arctigenin induces apoptosis in colon (HT-29), breast (in vitro/in vivo), lung and gastric cancer cells and chemosensitizes them to doxorubicin (preclinical).
inferred from digestive action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Safety, Cautions & Contraindications
Generally safe as a food plant. Allergic reactions are possible in those sensitive to Asteraceae. Avoid in pregnancy due to uterine-stimulating effects reported in animal studies. The burs (seed heads) can cause mechanical irritation of skin and eyes on contact. Not recommended in biliary obstruction.
Duke (2002) rates burdock as +++ and notes antibacterial, antimutagenic, antitumor, choleretic, diuretic, and prebiotic (bifidogenic) activities at the experimental level (score 1). The root is rich in inulin (a prebiotic fructooligosaccharide), which promotes growth of beneficial intestinal bacteria. Dose: 1–2 g dried root in tea three times daily, or 2–4 ml of tincture. Duke notes burdock's general safety, though it belongs to the Asteraceae family and can trigger reactions in sensitive individuals. It should be distinguished from belladonna and similar plants, which resemble it in early growth (Duke, 2002).
Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.
Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.
External Ids
Botanical Description
Robust biennial herb forming a large rosette of huge, heart-shaped (rhubarb-like), long-stalked leaves, dark green above and whitish-woolly beneath, in its first year. In the second year it sends up a tall, branching, grooved flowering stem bearing purple thistle-like flower heads enclosed in a globe of stiff, hooked bracts that ripen into the familiar clinging burrs.[1, 2]
Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]
Habitat
A common weed of disturbed ground, waste places, roadsides, field margins and riverbanks on rich, moist soils; native to Europe and temperate Asia and naturalised in North America and elsewhere.[2]
Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]
Harvesting
The root is dug at the end of the first growing season (autumn) or early in the second spring, before the flowering stem develops, when it is at its most tender and richest in inulin; leaves are picked through the first year, and the seed/fruit is collected from the dried burrs in the second autumn. Careful identification against deadly nightshade, whose root can resemble burdock, is essential before digging.[11]
The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]
Traditional Uses
Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]
Preparations
Dried or fresh root simmered in water as a traditional alterative and digestive decoction.
Tincture of the dried root, ethanol 45% V/V or 25% V/V, 8-12 ml three times daily per the EU herbal monograph. The monograph states the ethanol strength but no drug-extract ratio, so no 1:5 ratio is claimed here. Educational reference only, not a prescription.
Fresh root peeled and cooked as a root vegetable (gobo), continuing the traditional food-medicine use.
Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.
Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.
Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.
Dosage
The EU herbal monograph on Arctium lappa L., radix gives, for adults and elderly, a single dose of 2-6 g of the comminuted root as an infusion, 3 times daily; a powdered herbal substance at 350 mg 3-5 times daily, a liquid extract at 2-8 mL 3 times daily and a soft extract at 0.2 g per dose (1-2 g daily) are also listed. Not recommended under 18 years, and a practitioner should be consulted if symptoms persist beyond 2 weeks. Educational reference only, not a prescription.
The EU herbal monograph gives 8-12 mL three times daily, for tinctures in either 45% V/V or 25% V/V ethanol, in adults and elderly. Educational reference only, not a prescription.
The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Drug Class Interactions
Not documented
References & Sources
- Chan, Y.S., Cheng, L.N., Wu, J.H., Chan, E., Kwan, Y.W., Lee, S.M.Y., Leung, G.P.H., Yu, P.H.F. and Chan, S.W (2010) 'A review of the pharmacological effects of Arctium lappa (burdock)', Inflammopharmacology, 19(5), pp. 245--254. doi:10.1007/s10787-010-0062-4 Preclinical
https://doi.org/10.1007/s10787-010-0062-4 - de Souza, A.R.C., de Oliveira, T.L., Fontana, P.D., Carneiro, M.C., Corazza, M.L., de Messias Reason, I.J. and Bavia, L (2022) 'Phytochemicals and Biological Activities of Burdock (Arctium lappa L.) Extracts: A Review', Chemistry and Biodiversity, 19(11). doi:10.1002/cbdv.202200615 Preclinical
https://doi.org/10.1002/cbdv.202200615 - Yosri, N., Alsharif, S.M., Xiao, J., Musharraf, S.G., Zhao, C., Saeed, A., Gao, R., Said, N.S., Di Minno, A., Daglia, M., Guo, Z., Khalifa, S.A.M. and El-Seedi, H.R (2023) 'Arctium lappa (burdock): insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine', Biomedicine & Pharmacotherapy, 158, pp. 114104. doi:10.1016/j.biopha.2022.114104 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2022.114104 - Mondal, S.C. and Eun, J.B (2022) 'Mechanistic insights on burdock (Arctium lappa L.) extract effects on diabetes mellitus', Food Science and Biotechnology, 31(8), pp. 999--1008. doi:10.1007/s10068-022-01091-2 Preclinical
https://doi.org/10.1007/s10068-022-01091-2 - Shyam, M. and Sabina, E.P (2024) 'Harnessing the power of Arctium lappa root: a review of its pharmacological properties and therapeutic applications', Natural Products and Bioprospecting, 14(1), pp. 49. doi:10.1007/s13659-024-00466-8 Meta-analysis / review
https://doi.org/10.1007/s13659-024-00466-8 - Gao, Q., Yang, M. and Zuo, Z (2018) 'Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L', Acta Pharmacologica Sinica, 39(5), pp. 787-801. doi:10.1038/aps.2018.32 Traditional / reference
https://doi.org/10.1038/aps.2018.32 - Jin, X., Liu, S., Chen, S., Wang, L., Cui, Y., He, J., Fang, S., Li, J. and Chang, Y (2023) 'A systematic review on botany, ethnopharmacology, quality control, phytochemistry, pharmacology and toxicity of Arctium lappa L. fruit', Journal of Ethnopharmacology, 308, pp. 116223. doi:10.1016/j.jep.2023.116223 Meta-analysis / review
https://doi.org/10.1016/j.jep.2023.116223 - Shukla, S., Kakade, M., Cherian, S., Alagarasu, K. and Parashar, D (2024) 'Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication', Phytomedicine, 128, pp. 155491. doi:10.1016/j.phymed.2024.155491 Preclinical
https://doi.org/10.1016/j.phymed.2024.155491 - Nascimento, B.A.C., Gardinassi, L.G., Silveira, I.M.G., Gallucci, M.G., Tome, M.A., Oliveira, J.F.D., Moreira, M.R.A., Meirelles, A.F.G., Faccioli, L.H., Tefe-Silva, C. and Zoccal, K.F (2019) 'Arctium lappa extract suppresses inflammation and inhibits melanoma progression', Medicines, 6(3), pp. 81. doi:10.3390/medicines6030081 Preclinical
https://doi.org/10.3390/medicines6030081 - Lu, N., Wei, J., Gong, X., Tang, X., Zhang, X., Xiang, W., Liu, S., Luo, C. and Wang, X (2023) 'Preventive effect of Arctium lappa polysaccharides on acute lung injury through anti-inflammatory and antioxidant activities', Nutrients, 15(23), pp. 4946. doi:10.3390/nu15234946 Preclinical
https://doi.org/10.3390/nu15234946 - Moro, T.M.A. and Clerici, M.T.P.S (2020) 'Burdock (Arctium lappa L) roots as a source of inulin-type fructans and other bioactive compounds: Current knowledge and future perspectives for food and non-food applications', Food Research International. doi:10.1016/j.foodres.2020.109889 Preclinical
https://doi.org/10.1016/j.foodres.2020.109889 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Arctium lappa L., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Xu, Z., Li, Y., Jiang, D. and Deng, L (2008) 'Arctium lappa L.: A review of its traditional uses, phytochemistry, and pharmacology', 121(2), pp. 167--184. Traditional / reference
https://scholar.google.com/scholar?q=Arctium%20lappa%20L.%3A%20A%20review%20of%20its%20traditional%20uses%2C%20phytochemistry%2C%20and%20pharmacology - Romualdo, G.R., Silva, E.D.A., Da Silva, T.C., Aloia, T.P.A., Nogueira, M.S., De Castro, I.A. and others (2019) 'Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis', Environmental Toxicology, 35(4), pp. 518--527. doi:10.1002/tox.22887 Preclinical
https://doi.org/10.1002/tox.22887 - Chen, Y.-F. and Liu, R.-Z. and Ying, W.-W. and Yang, Y.-N. and Xiang, S.-F. and Shao, X.-J. and Cao, J. and Zhang, Y.-Q. and Yang, B. and He, Q.-J. and Ying, M.-D (2022) 'Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells', Acta Pharmacologica Sinica, 44(3), pp. 661-669. doi:10.1038/s41401-022-00992-6 Preclinical
https://doi.org/10.1038/s41401-022-00992-6 - Shi, H. and Zhao, L. and Guo, X. and Fang, R. and Zhang, H. and Dong, G. and Fu, J. and Yan, F. and Zhang, J. and Ning, Z. and Ma, Q. and Li, Z. and Li, C. and Dai, J. and Si, C. and Xiong, H (2020) 'Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/beta-Catenin Signaling', International Journal of Molecular Sciences, 21(17), pp. 6357. doi:10.3390/ijms21176357 Preclinical
https://doi.org/10.3390/ijms21176357 - Li, Q.-C. and Liang, Y. and Tian, Y. and Hu, G.-R (2016) 'Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway', Journal of BUON, 21(1), pp. 87-94. Preclinical
https://scholar.google.com/scholar?q=Arctigenin%20induces%20apoptosis%20in%20colon%20cancer%20cells%20through%20ROS/p38MAPK%20pathway - Lee, K.-S. and Lee, M.-G. and Kwon, Y.-S. and Nam, K.-S (2020) 'Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells', International Journal of Molecular Sciences, 21(8), pp. 2997. doi:10.3390/ijms21082997 Preclinical
https://doi.org/10.3390/ijms21082997 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Bryson, P.D. and Watanabe, A.S. and Rumack, B.H. and Murphy, R.C (1978) 'Burdock root tea poisoning. Case report involving a commercial preparation', JAMA, 239(20), pp. 2157. Available at: https://pubmed.ncbi.nlm.nih.gov/642161/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/642161/ - Berdai, M.A. and Labib, S. and Chetouani, K. and Harandou, M (2012) 'Atropa belladonna intoxication: a case report', Pan African Medical Journal, 11, pp. 72. Available at: https://pubmed.ncbi.nlm.nih.gov/22655106/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22655106/ - Oerlemans, C. and de Vries, I. and van Riel, A.J.H.P (2017) 'Anticholinergic syndrome caused by contaminated herbal tea; acting swiftly to identify the source', Nederlands Tijdschrift voor Geneeskunde, 161, pp. D1261. Available at: https://pubmed.ncbi.nlm.nih.gov/28612694/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/28612694/
- Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
https://doi.org/10.1016/j.phrs.2020.105085 - Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth - Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
https://doi.org/10.1055/s-0030-1250606 - Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
https://doi.org/10.1055/s-0032-1315042 - Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
https://doi.org/10.1002/ptr.1108 - Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
https://doi.org/10.1021/np200336g - Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
https://doi.org/10.1021/acs.jnatprod.7b00654 - Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
https://doi.org/10.1016/j.phytol.2017.03.012 - Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
https://doi.org/10.1038/sj.clpt.6100222 - Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
https://doi.org/10.1016/j.fct.2018.07.033 - Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
https://doi.org/10.1016/j.fitote.2010.06.006 - Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
https://doi.org/10.1016/j.ejmech.2021.113839 - World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
https://doi.org/10.3109/00498251003592683 - Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
https://doi.org/10.1016/j.clpt.2005.01.009 - McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
https://doi.org/10.1124/dmd.120.091041 - Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
https://doi.org/10.1155/2021/2074610 - Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ - Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
https://doi.org/10.1001/archinte.157.17.2007 - North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.